• 울산대학교 의과대학 박사
• 울산대학교 의과대학 석사
• 순천향대학교 의과대학 졸업

• 2024-현재  | 이대서울병원 유방암센터장
• 2026-현재  | 이대서울병원 외과 부교수
• 2024-2026  | 이대서울병원 외과 임상부교수
• 2021-2024  | 이대목동병원 외과 임상조교수
• 2019-2021  | 서울아산병원 유방외과 진료조교수
• 2017  | 미국 뉴욕 Memorial Sloan Kettering Cancer Center 단기 연수
• 2016-2019  | 서울아산병원 유방외과 전임의
• 2014-2016  | 국방부 외과 과장
• 2013-2014  | 한국-필리핀 합동 지원단 (ARAW 부대) 파병 - 외과 제1과장
• 2009-2013  | 서울아산병원 외과 전공의
• 2008-2009  | 순천향대학교 부천병원 인턴

• 2023  | 한국 로봇 내시경 최소 침습 유방 수술 연구회 기획위원
• 2023  | 한국유방암학회 국제위원회 아시아분과 부위원장
• 2023  | 한국유방암학회 교육위원회 위원
• 2016  | 한국유방암학회 정회원
• 2009  | 대한외과학회 정회원

•  Survival pattern in male breast cancer: distinct from female breast cancer.  Frontiers in Oncology. 2024-06. 
•  Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.  European Journal of Radiology. 2024-02. 
•  Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.  International Journal of Surgery. 2024-02. 
•  Age-Related Incidence and Peak Occurrence of Contralateral Breast Cancer.  JAMA Network Open. 2023-12. 
•  Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer.  JAMA Network Open. 2023-09. 
•  Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.  Annals of Surgical Oncology. 2022-12. 
•  Plasma proteome signature to predict the outcome of breast cancer patients receiving neoadjuvant chemotheraphy.  Cancers. 2021-11. 
•  Axillary lymph node dissection and prognosis after neoadjuvant chemotherapy and neoadjuvant endocrine therapy in young women with ER-positive/HER2-negative, lymph node-positive breast cancer: Surgical results and long-term survival from the NEST randomized clinical trial.  Frontiers in Oncology. 2021-09. 
•  Patient-Reported Outcomes from Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy with Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients with Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer.  Frontiers in Oncology. 2021-07. 
•  Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.  Scientific Reports. 2020-10. 
•  The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.  PLoS One. 2020-09. 
•  Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer.  Breast cancer research and treatment. 2020-01. 
•  Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen.  Journal of breast cancer. 2019-08. 
•  Clinical implication of HER2 status in hormone receptor-positive mucinous breast Cancer. Annals of surgical oncology.  Annals of surgical oncology. 2019-07. 
•  Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.  Korean journal of hepato-biliary-pancreatic surgery. 2012-11. 

• 유방암 환자를 위한 치료 안내서 8판

  영창출판사 | 2022-08

• 유방암 환자를 위한 치료 안내서 7판

  영창출판사 | 2019-02

• [데일리메디] “젊은 유방암 환자, 임신·출산 포기 안해도 된다” 2026-09-30